has announced a partnership with Catalent (NYSE:CTLT) Pharma Solutions, LLC for the production of JOTROL™ softgel capsules. According to InvestingPro analysis, the company's stock is trading ...

The pharma group’s chief executive, David Ricks, has told the Financial Times that the authorities should examine the deal closely, given that Catalent’s client roster includes “in excess of ...

and Board member of Catalent, said "I am excited to work closely with these new Board members as we drive continued growth as an independent CDMO delivering unparalleled service to our pharma and ...

Novo Nordisk has taken the bold step of buying three manufacturing facilities from contract development and manufacturing organisation Catalent as it tries to meet surging demand for its diabetes ...

Beyond manufacturing capacity, sponsors seek expertise in specialized drug formulations, regulatory affairs, and service ...

The key to success in developing and bringing mRNA-, DNA-, viral vector- and cell-based therapies to the market is having a partner like Catalent Working with the right integrated partner can help ...